These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 26208874

  • 1. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
    Volkow ND, Wang GJ, Smith L, Fowler JS, Telang F, Logan J, Tomasi D.
    Neuroimage; 2015 Nov 01; 121():20-8. PubMed ID: 26208874
    [Abstract] [Full Text] [Related]

  • 2. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.
    Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J.
    J Neurosci; 2001 Dec 01; 21(23):9414-8. PubMed ID: 11717374
    [Abstract] [Full Text] [Related]

  • 3. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J, Liu XD, Han M, Lv RB, Wang YK, Zhang GM, Li Y.
    Addict Biol; 2017 Jan 01; 22(1):229-234. PubMed ID: 26040446
    [Abstract] [Full Text] [Related]

  • 4. Decreased dopamine activity predicts relapse in methamphetamine abusers.
    Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS.
    Mol Psychiatry; 2012 Sep 01; 17(9):918-25. PubMed ID: 21747399
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.
    Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA.
    J Neurosci; 2009 Nov 25; 29(47):14734-40. PubMed ID: 19940168
    [Abstract] [Full Text] [Related]

  • 7. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM.
    Synapse; 2002 Mar 01; 43(3):181-7. PubMed ID: 11793423
    [Abstract] [Full Text] [Related]

  • 8. Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
    Koochesfahani KM, de la Fuente-Fernández R, Sossi V, Schulzer M, Yatham LN, Ruth TJ, Blinder S, Stoessl AJ.
    Mov Disord; 2006 Jul 01; 21(7):970-5. PubMed ID: 16570297
    [Abstract] [Full Text] [Related]

  • 9. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
    McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA.
    J Neurosci; 1998 Oct 15; 18(20):8417-22. PubMed ID: 9763484
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP, Lacan G, Desalles AA, Phelps ME.
    Synapse; 2000 Mar 15; 35(4):243-9. PubMed ID: 10657033
    [Abstract] [Full Text] [Related]

  • 12. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.
    Proebstl L, Kamp F, Manz K, Krause D, Adorjan K, Pogarell O, Koller G, Soyka M, Falkai P, Kambeitz J.
    Eur Psychiatry; 2019 Jun 15; 59():15-24. PubMed ID: 30981746
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of genetic variants on striatal dopamine transporter and D2 receptor binding after TBI.
    Wagner AK, Scanlon JM, Becker CR, Ritter AC, Niyonkuru C, Dixon CE, Conley YP, Price JC.
    J Cereb Blood Flow Metab; 2014 Aug 15; 34(8):1328-39. PubMed ID: 24849661
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
    Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN.
    Am J Psychiatry; 2001 Mar 15; 158(3):377-82. PubMed ID: 11229977
    [Abstract] [Full Text] [Related]

  • 17. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.
    Arch Gen Psychiatry; 2007 Aug 15; 64(8):932-40. PubMed ID: 17679638
    [Abstract] [Full Text] [Related]

  • 18. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.
    Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR.
    Psychopharmacology (Berl); 2006 Apr 15; 185(3):327-38. PubMed ID: 16518646
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.